Published • loading... • Updated
Study Details New ctDNA Isolation Method for Liquid Biopsy
Summary
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cancer Cell Diagnostics Launches CTC-Based Liquid Biopsy Test
The CellSight DNA assay isolates intact circulating tumor cells rather than cell-free DNA to perform genomic profiling from a single blood draw. Cancer Cell Diagnostics announced the commercial launch of its CellSight DNA test, which uses intact circulating tumor cells to analyze cancer. This approach differs from most blood-based liquid biopsy tests that analyze cell-free circulating tumor DNA, which are short fragments shed into the bloodstrea…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
